Harri Blåfield

1.8k total citations
12 papers, 672 citations indexed

About

Harri Blåfield is a scholar working on Rheumatology, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Harri Blåfield has authored 12 papers receiving a total of 672 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Rheumatology, 6 papers in Hematology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Harri Blåfield's work include Rheumatoid Arthritis Research and Therapies (11 papers), Autoimmune and Inflammatory Disorders Research (6 papers) and Lymphoma Diagnosis and Treatment (5 papers). Harri Blåfield is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (11 papers), Autoimmune and Inflammatory Disorders Research (6 papers) and Lymphoma Diagnosis and Treatment (5 papers). Harri Blåfield collaborates with scholars based in Finland. Harri Blåfield's co-authors include Hannu Kautiainen, Marjatta Leirisalo‐Repo, Markku Korpela, Timo Möttönen, Pekka Hannonen, Kari Puolakka, Leena Laasonen, Markku Hakala, Leena Paimela and Kaisa Vuori and has published in prestigious journals such as Annals of the Rheumatic Diseases, Arthritis Research & Therapy and Clinical Rheumatology.

In The Last Decade

Harri Blåfield

12 papers receiving 640 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harri Blåfield Finland 10 592 243 125 108 73 12 672
D Hofman Netherlands 4 499 0.8× 207 0.9× 75 0.6× 73 0.7× 61 0.8× 4 544
L. Heimans Netherlands 13 446 0.8× 156 0.6× 98 0.8× 81 0.8× 66 0.9× 29 538
E. Lubberts Netherlands 3 745 1.3× 316 1.3× 70 0.6× 128 1.2× 127 1.7× 4 879
Robin Munro United Kingdom 12 551 0.9× 202 0.8× 110 0.9× 73 0.7× 109 1.5× 16 740
U. von Hinüber Germany 8 330 0.6× 169 0.7× 95 0.8× 67 0.6× 123 1.7× 13 449
Anne‐Barbara Mongey United States 12 274 0.5× 65 0.3× 67 0.5× 58 0.5× 92 1.3× 21 455
Moetaza M. Soliman Egypt 9 281 0.5× 126 0.5× 82 0.7× 53 0.5× 176 2.4× 24 449
Gary Kunkel United States 10 318 0.5× 202 0.8× 74 0.6× 54 0.5× 111 1.5× 22 552
Greet Esselens Belgium 6 287 0.5× 80 0.3× 44 0.4× 60 0.6× 50 0.7× 7 428
B Svensson Sweden 7 447 0.8× 168 0.7× 28 0.2× 100 0.9× 38 0.5× 7 527

Countries citing papers authored by Harri Blåfield

Since Specialization
Citations

This map shows the geographic impact of Harri Blåfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harri Blåfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harri Blåfield more than expected).

Fields of papers citing papers by Harri Blåfield

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harri Blåfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harri Blåfield. The network helps show where Harri Blåfield may publish in the future.

Co-authorship network of co-authors of Harri Blåfield

This figure shows the co-authorship network connecting the top 25 collaborators of Harri Blåfield. A scholar is included among the top collaborators of Harri Blåfield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harri Blåfield. Harri Blåfield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Puolakka, Kari, Hannu Kautiainen, Harri Blåfield, et al.. (2015). Impact of physicians’ adherence to treat-to-target strategy on outcomes in early rheumatoid arthritis in the NEO-RACo trial. Scandinavian Journal of Rheumatology. 44(6). 449–455. 18 indexed citations
2.
3.
Leirisalo‐Repo, Marjatta, Hannu Kautiainen, Leena Laasonen, et al.. (2012). Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study). Annals of the Rheumatic Diseases. 72(6). 851–857. 69 indexed citations
4.
5.
Puolakka, Kari, Hannu Kautiainen, Timo Möttönen, et al.. (2009). Use of the Stanford Health Assessment Questionnaire in estimation of long‐term productivity costs in patients with recent‐onset rheumatoid arthritis. Scandinavian Journal of Rheumatology. 38(2). 96–103. 13 indexed citations
6.
Tanskanen, Maarit, et al.. (2009). Hereditary gelsolin amyloidosis mimicking Sjögren’s syndrome. Clinical Rheumatology. 28(11). 1351–1354. 11 indexed citations
7.
Mäkinen, Heidi, Hannu Kautiainen, Pekka Hannonen, et al.. (2007). Sustained remission and reduced radiographic progression with combination disease modifying antirheumatic drugs in early rheumatoid arthritis.. PubMed. 34(2). 316–21. 97 indexed citations
8.
Luukkainen, Reijo, Tuulikki Sokka, Hannu Kautiainen, et al.. (2007). Prognosis of 5-year radiographic erosions of the wrist according to early, late, and persistent wrist swelling or tenderness in patients with early rheumatoid arthritis.. PubMed. 34(1). 50–3. 6 indexed citations
9.
Konttinen, Liisa, Harri Blåfield, Kaisa Vuori, et al.. (2006). Effectiveness of anakinra in rheumatic disease in patients naive to biological drugs or previously on TNF blocking drugs: an observational study. Clinical Rheumatology. 25(6). 882–884. 20 indexed citations
10.
Arkela-Kautiainen, Marja, Hannu Kautiainen, Toini Uutela, et al.. (2005). Evaluation of the MDHAQ in Finnish patients with RA [corrected].. PubMed. 32(8). 1426–31. 8 indexed citations
11.
12.
Korpela, Markku, Leena Laasonen, Pekka Hannonen, et al.. (2004). Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease‐modifying antirheumatic drugs: Five‐year experience from the FIN‐RACo study. Arthritis & Rheumatism. 50(7). 2072–2081. 195 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D Hofman Breakdown of academic impact, for papers by L. Heimans Breakdown of academic impact, for papers by E. Lubberts Breakdown of academic impact, for papers by Robin Munro Breakdown of academic impact, for papers by U. von Hinüber Breakdown of academic impact, for papers by Anne‐Barbara Mongey Breakdown of academic impact, for papers by Moetaza M. Soliman Breakdown of academic impact, for papers by Gary Kunkel Breakdown of academic impact, for papers by Greet Esselens Breakdown of academic impact, for papers by B Svensson
Rankless by CCL
2026